Israel Englander Milestone Pharmaceuticals Inc. Call Options Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$1.67 - $3.39 $394,788 - $801,396
236,400 New
236,400 $394,000
Q4 2022

Feb 14, 2023
BUY
$3.53 - $9.5 $470,902 - $1.27 Million
133,400 Added 200.3%
200,000 $792,000
Q3 2022

Nov 14, 2022
BUY
$5.86 - $9.43 $390,276 - $628,038
66,600 New
66,600 $612,000

Others Institutions Holding MIST

# of Institutions
45
Shares Held
28.7M
Call Options Held
200
Put Options Held
0
View Full List

About Milestone Pharmaceuticals Inc.

MIST Quotes by TradingView
  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $55.5M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email